64Cu-SAR-bis-PSMA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu-SAR-bis-PSMA, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy [Phase 2]